Abstract
Infective endocarditis (IE) is a serious and deadly disease. Despite medical advances over the past half century, more than one half of patients with IE suffer a serious complication, and the mortality rate remains approximately 20% during the initial hospitalization and approaches 40% at 1 year. In patients with documented IE, the treatment centers on two main aspects: effective antibiotic therapy and consideration of surgical therapy. Effective antibiotic therapy is the mainstay of treatment and focuses on sustained bactericidal concentrations tailored specifically to the causative microorganism. Surgical therapy is also an important option for many patients with IE. The goals of surgical therapy are to eradicate the focus of infection, to repair endocardial destruction, and to prevent the development of complications and relapse of infection. Ideally, surgical therapy should offer a survival advantage over medical therapy alone. Recent evidence supports the survival benefit of surgery in patients with IE, specifically in those with heart failure and complicated, left-sided IE. Future therapeutic strategies may include broader indications for surgery, as well as new treatments such as immune-modulating agents.
Similar content being viewed by others
References and Recommended Reading
American Heart Association: 1997 Heart and Stroke Statistical Update. Dallas, TX: American Heart Association; 1997.
Benn M, Hagelskjaer LH, Tvede M: Infective endocarditis, 1984 through 1993: a clinical and microbiologic survey. J Intern Med 1997, 242:15–22.
Cabell CH, Jollis JG, Peterson GE, et al.: Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 2002, 162:90–94.
Nissen H, Nielsen F, Frederiksen M, et al.: Native valve infective endocarditis in the general population: a 10-year survey of the clinical picture during the 1980s. Eur Heart J 1992, 13:872–877.
Bayer AS, Bolger AF, Taubert KA, et al.: Diagnosis and management of infective endocarditis and its complications. Circulation 1998, 98:2936–2948.
Li JS, Sexton DJ, Mick N, et al.: Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000, 30:633–638.
Dajani AS, Taubert KA, Wilson W, et al.: Prevention of bacterial endocarditis: recommendations by the American Heart Association. Clin Infect Dis 1997, 25:1448–1458.
Pelletier L, Petersdorf R: Infective endocarditis: a review of 125 cases from the University of Washington Hospitals, 1963–1972. Medicine (Baltimore) 1977, 56:287–313.
Wilson WR, Karchmer A, Dajani AS, et al.: Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. JAMA 1995, 274:1706–1713.
Olaison L, Pettersson G: Current best practices and guidelines Indications for surgical intervention in infective endocarditis. Infect Dis Clin North Am 2002, 16:453–475.
Cabell CH, Abrutyn E: Progress toward a global understanding of infective endocarditis. Infect Dis Clin North Am 2002, 16:255–272.
Delahaye F, Goulet V, Lacassin F, et al.: Characteristics of infective endocarditis in France 1991: a one-year survey. Eur Heart J 1995, 16:394–401.
Hogevik H, Olaison L, Andersson R, et al.: Epidemiologic aspects of infective endocarditis in an urban population. Medicine (Baltimore) 1995, 74:324–339.
Cabell CH, Pond KK, Peterson GE, et al.: The risk of stroke and death in patients with aortic and mitral valve endocarditis. Am Heart J 2001, 142:75–80.
HoenB, Alla F, Selton-Suty C, et al.: Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002, 288:75–81. This reference is one of the best epidemiologic studies of patients with endocarditis. Importantly, this study is a followup to one performed in 1991, allowing for important observations on the changing nature of endocarditis.
Hasbun R, Vikram HR, Barakat LA, et al.: Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA 2003, 289:1933–1940.
Chu V, Cabell C, Benjamin D, et al.: Early predictors of in-hospital death in infective endocarditis. Circulation 2004, 109:1745–1749.
VikramHR, Buenconsejo J, Hasbun R, Quagliarello VJ: Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis. JAMA 2003, 290:3207–3214. This article is a high quality case-control study that examines the impact of valve surgery on survival in patients with endocarditis. In this analysis, the authors use propensity scoring techniques to control for the nonrandom assignment to surgical intervention.
Moon M, Miller C, Moore K, et al.: Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis. Ann Thorac Surg 2001, 71:1164–1171.
Petti C, Fowler VG: Staphylococcus aureus bacteremia and endocarditis. Infect Dis Clin North Am 2002, 16:413–435.
Vastag B: New vaccine decreases rate of nosocomial infections. JAMA 2001, 285:1565–1566.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cabell, C.H., Wang, A. Current treatment options for patients with endocarditis: The evolving indications for cardiac surgery. Curr Treat Options Cardio Med 6, 441–449 (2004). https://doi.org/10.1007/s11936-004-0001-z
Issue Date:
DOI: https://doi.org/10.1007/s11936-004-0001-z